Specialist consultant-led care for Type 1 and Type 2 diabetes, including HbA1c optimisation, insulin review, continuous glucose monitoring, and access to the latest evidence-based therapies.
Dr Syed Kazmi, Consultant Endocrinologist at Naas Cardiology & Endocrinology Clinic in Naas, Co. Kildare (IMC 213626), provides specialist assessment and management of this condition. Appointments are available on Saturdays & Sundays at Suite 5, Vista Primary Care Clinic, Ballymore Road, Naas. To book, call 089 656 7597. This condition can also be assessed via an online diabetes consultation. For day-to-day self-care guidance, see our diabetes patient information guide.
Diabetes mellitus is a chronic metabolic condition characterised by elevated blood glucose levels, resulting from defects in insulin secretion, insulin action, or both. It is one of the most common long-term conditions managed in specialist endocrinology practice.
Type 1 diabetes is an autoimmune condition in which the immune system destroys insulin-producing beta cells in the pancreas. It typically presents in childhood or early adulthood and requires lifelong insulin therapy.
Type 2 diabetes accounts for the majority of diabetes cases and involves a combination of insulin resistance and progressive beta-cell dysfunction. It is strongly associated with excess weight, physical inactivity, and family history, though it can occur in lean individuals.
HbA1c (glycated haemoglobin) is the primary test used to diagnose diabetes and monitor long-term glucose control. The following thresholds are used in clinical practice:
| Category | HbA1c mmol/mol | HbA1c % | Clinical Interpretation |
|---|---|---|---|
| Normal | < 42 mmol/mol | < 6.0% | No diabetes or prediabetes |
| Prediabetes / At Risk | 42–47 mmol/mol | 6.0–6.4% | Impaired glucose regulation; lifestyle intervention indicated |
| Diabetes Diagnosis | ≥ 48 mmol/mol | ≥ 6.5% | Diabetes confirmed on two separate occasions |
| Target (most adults, Type 2) | 48–53 mmol/mol | 6.5–7.0% | Well-controlled; reduces risk of complications |
| Target (Type 1 / intensive) | 48–58 mmol/mol | 6.5–7.5% | Individualised based on hypoglycaemia risk |
| Target (frail / elderly) | 58–70 mmol/mol | 7.5–8.5% | Relaxed target to avoid hypoglycaemia |
| Diabetes Remission | < 48 mmol/mol | < 6.5% | Sustained ≥ 3 months without glucose-lowering medication |
Symptoms of uncontrolled diabetes can include:
Many people with Type 2 diabetes have no symptoms at diagnosis, which is why routine screening is important. If you are experiencing any of the above, please speak with your GP.
Dr Syed Kazmi provides consultant-level diabetes management, offering a comprehensive assessment of glucose control, complications risk, and treatment optimisation.
Detailed review of glycaemic control with personalised HbA1c targets. We balance optimal glucose management with quality of life, avoiding unnecessary hypoglycaemia.
Assessment and adjustment of insulin regimens for both Type 1 and Type 2 diabetes, including basal-bolus regimens, pre-mixed insulins, and insulin pump considerations.
Review and interpretation of CGM and flash glucose monitoring (FreeStyle Libre) data. Guidance on time-in-range targets and using technology to improve outcomes.
Access to the latest evidence-based treatments including GLP-1 receptor agonists and SGLT-2 inhibitors, with careful selection based on individual risk profiles.
Assessment for microvascular and macrovascular complications including nephropathy, neuropathy, and retinopathy risk stratification.
Integrated review of cardiovascular risk factors including blood pressure, lipids, and weight, alongside glucose management for comprehensive metabolic care.
A diabetes consultation at our clinic typically includes a detailed clinical history review, assessment of current blood glucose control and HbA1c trends, medication review, and discussion of lifestyle factors. Where appropriate, we may arrange additional investigations including renal function, lipid profile, and specialist referrals.
We work collaboratively with your GP and any other healthcare professionals involved in your care. A detailed clinic letter is sent to your referring physician following each consultation.
Our clinic is led by Dr Syed Kashif Hussain Kazmi, Consultant Endocrinologist (IMC: 213626), with dedicated experience in diabetes management across a wide spectrum of complexity.
Book a private consultation with Dr Kazmi, Consultant Endocrinologist, at our Naas clinic. Self-referral welcome. GP referral preferred.
Dr Kazmi manages Type 1, Type 2 and complex diabetes, insulin and CGM optimisation and GLP-1 therapy, in person at weekends in Naas or by video most weekday evenings, at the same fee.
Diabetes Specialist Ireland →